IMMUNE DESIGN CORP. (IMDZ) has 50 open-market insider trades by 20 insiders since 2014. The most active filer is Lewis W. Coleman, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Peter Svennilson | Dir10% Owner | — | 3 | $31.8M | 2017-10-27 |
| David V. Goeddel | 10% Owner | — | 2 | $26.8M | 2017-10-27 |
| Leo Guthart | 10% Owner | — | 6 | $10.8M | 2018-01-08 |
| ProQuest Associates IV LLC | 10% | — | 2 | $8.8M | 2015-04-01 |
| Jay Moorin | 10% | — | 3 | $6.4M | 2015-05-12 |
| Brian G. Atwood | Dir10% | — | 1 | $5.3M | 2014-07-29 |
| Versant Venture Capital III, L.P. | 10% | — | 1 | $5.3M | 2014-07-29 |
| ProQuest Investments IV, L.P. | 10% | — | 5 | $5.2M | 2015-04-24 |
| Alain Schreiber | 10% | — | 2 | $4.7M | 2015-04-16 |
| Partners Management Viii Llc Alta | 10% | — | 1 | $3.6M | 2014-07-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Carlos V. Paya | CEO & President | Sell | $41K | 2019-01-07 |
| Jan Henrik ter Meulen | CSO | Sell | $11K | 2019-01-07 |
| Sergey Yurasov | CMO & VP | Sell | $11K | 2019-01-07 |
| Stephen R. Brady | VP | Sell | $17K | 2019-01-07 |
| Biotechnology Value Trading Fund OS LP | 10% Owner | Sell | $3.3M | 2018-12-04 |
| Leo Guthart | 10% Owner | Buy | $78K |
Companies that share insiders with IMDZ, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2018-01-08 |
| Stephen R. Brady | EVP & Strategy & Finance | Sell | $14K | 2018-01-05 |
| Jan Henrik ter Meulen | Chief Scientific Officer | Sell | $8K | 2018-01-05 |
| Sergey Yurasov | Sr. VP & Clinic. Devel. & CMO | Sell | $3K | 2018-01-05 |
| Carlos V. Paya | President | Sell | $33K | 2018-01-05 |
| Sergey Yurasov | Sr. VP & Clinic. Devel. & CMO | Sell | $3K | 2018-01-04 |
| Lewis W. Coleman | Director | Buy | $225K | 2017-11-02 |
| Franklin M. Berger | Director | Buy | $115K | 2017-10-30 |
| Peter Svennilson | Director & 10% Owner | Buy | $22.0M | 2017-10-27 |
| Lewis W. Coleman | Director | Buy | $265K | 2017-10-27 |